or
forgot password
  • cancer clinical trials in scranton, PA

  • Comparison of Combination Chemotherapy Regimens in Treating Older Women Who Have Undergone Surgery for Breast Cancer
    Hematology and Oncology Associates
    Scranton, Pennsylvania 18510
    Breast Cancer
    Radiation Therapy in Treating Patients With Stage II or Stage III Prostate Cancer
    Mercy Hospital Cancer Center - Scranton
    Scranton, Pennsylvania 18501
    Prostate Cancer
    Radiation Therapy Plus Combination Chemotherapy in Treating Patients With Small Cell Lung Cancer
    Mercy Hospital Cancer Center - Scranton
    Scranton, Pennsylvania 18501
    Lung Cancer
    Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
    Mercy Hospital Cancer Center - Scranton

    Trial Locations
    Mercy Hospital Cancer Center - Scranton
    Hematology and Oncology Associates of Northeastern Pennsylvania
    Breast Cancer
    Pilocarpine in Preventing Mucositis and Dry Mouth in Patients Receiving Radiation Therapy for Head and Neck Cancer
    Mercy Hospital Cancer Center - Scranton
    Scranton, Pennsylvania 18501
    Head and Neck Cancer, Oral Complications
    Amifostine in Treating Patients With Stage II or Stage III Non-small Cell Lung Cancer
    Mercy Hospital Cancer Center - Scranton
    Scranton, Pennsylvania 18501
    Drug/Agent Toxicity by Tissue/Organ, Lung Cancer, Oral Complications, Radiation Toxicity
    Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With Hodgkin's Lymphoma
    Mercy Hospital Cancer Center - Scranton

    Trial Locations
    Mercy Hospital Cancer Center - Scranton
    Hematology and Oncology Associates
    Lymphoma
    Radiation Therapy and Combination Chemotherapy in Treating Patients With Stage II or Stage III Bladder Cancer
    Mercy Hospital Cancer Center - Scranton
    Scranton, Pennsylvania 18501
    Bladder Cancer
    Hormone Therapy and Radiation Therapy in Treating Patients With Prostate Cancer
    Mercy Hospital Cancer Center - Scranton
    Scranton, Pennsylvania 18501
    Prostate Cancer
    Radiation Therapy Followed by Carmustine in Treating Patients Who Have Supratentorial Glioblastoma Multiforme
    Mercy Hospital Cancer Center - Scranton
    Scranton, Pennsylvania 18501
    Brain and Central Nervous System Tumors
    Evaluation of Memory Skills in Patients Receiving Radiation Therapy for Brain Metastases
    Mercy Hospital Cancer Center - Scranton
    Scranton, Pennsylvania 18501
    Cognitive/Functional Effects, Metastatic Cancer, Radiation Toxicity
    Chemotherapy and Radiation Therapy Following Surgery in Treating Patients With Head and Neck Cancer
    Mercy Hospital Cancer Center - Scranton
    Scranton, Pennsylvania 18501
    Head and Neck Cancer
    Paclitaxel With or Without Carboplatin in Treating Women With Metastatic Breast Cancer
    Scranton Hematology-Oncology
    Scranton, Pennsylvania 18510
    Breast Cancer
    Hormone Therapy Plus Chemotherapy in Treating Patients With Prostate Cancer
    Mercy Hospital Cancer Center - Scranton
    Scranton, Pennsylvania 18501
    Prostate Cancer
    Four Versus Six Cycles of Cyclophosphamide/Doxorubicin or Paclitaxel in Adjuvant Breast Cancer
    Mercy Hospital Cancer Center - Scranton

    Trial Locations
    Mercy Hospital Cancer Center - Scranton
    Hematology and Oncology Associates of Northeastern Pennsylvania
    Breast Cancer
    Anastrozole or Tamoxifen in Treating Postmenopausal Women With Ductal Carcinoma in Situ Who Are Undergoing Lumpectomy and Radiation Therapy
    Mercy Hospital Cancer Center - Scranton

    Trial Locations
    Mercy Hospital Cancer Center - Scranton
    Hematology and Oncology Associates
    Breast Cancer
    Combination Chemotherapy in Treating Patients With Stage III, Stage IV, or Recurrent Endometrial Cancer
    Mercy Hospital Cancer Center - Scranton

    Trial Locations
    Mercy Hospital Cancer Center - Scranton
    Hematology and Oncology Associates of Northeastern Pennsylvania
    Endometrial Cancer
    S0221 Adjuvant Doxorubicin, Cyclophosphamide, and Paclitaxel in Treating Patients With Breast Cancer
    Hematology and Oncology Associates of Northeastern Pennsylvania
    Scranton, Pennsylvania 18510
    Breast Cancer
    Interferon Alfa-2b With or Without Bevacizumab in Treating Patients With Advanced Renal Cell Carcinoma (Kidney Cancer)
    Mercy Hospital Cancer Center - Scranton

    Trial Locations
    Mercy Hospital Cancer Center - Scranton
    Hematology and Oncology Associates
    Kidney Cancer
    Rituximab in Treating Patients With Low Tumor Burden Indolent Non-Hodgkin's Lymphoma
    Mercy Hospital Cancer Center - Scranton

    Trial Locations
    Mercy Hospital Cancer Center - Scranton
    Hematology and Oncology Associates of Northeastern Pennsylvania
    Lymphoma
    Comparison of Combination Chemotherapy Regimens With or Without Cetuximab in Treating Patients Who Have Undergone Surgery For Stage III Colon Cancer
    Community Medical Center

    Trial Locations
    Community Medical Center
    Hematology and Oncology Associates of North East Pennsylvania
    Scranton Hematology Oncology
    Mercy Hospital
    Adenocarcinoma of the Colon, Stage III Colon Cancer
    Tipifarnib in Treating Patients With Acute Myeloid Leukemia in Remission
    Scranton Hematology Oncology

    Trial Locations
    Scranton Hematology Oncology
    Mercy Hospital
    Adult Acute Megakaryoblastic Leukemia (M7), Adult Acute Minimally Differentiated Myeloid Leukemia (M0), Adult Acute Monocytic Leukemia (M5b), Adult Acute Myeloblastic Leukemia With Maturation (M2), Adult Acute Myeloblastic Leukemia Without Maturation (M1), Adult Acute Myeloid Leukemia, Adult Acute Myeloid Leukemia in Remission, Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Inv(16)(p13;q22), Adult Acute Myeloid Leukemia With t(16;16)(p13;q22), Adult Acute Myeloid Leukemia With t(8;21)(q22;q22), Adult Acute Myelomonocytic Leukemia (M4), Adult Erythroleukemia (M6a), Recurrent Adult Acute Myeloid Leukemia, Refractory Anemia With Excess Blasts in Transformation
    Oxaliplatin, Leucovorin, and Fluorouracil With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II Colon Cancer
    Hematology and Oncology Associates of North East Pennsylvania

    Trial Locations
    Hematology and Oncology Associates of North East Pennsylvania
    Scranton Hematology Oncology
    Mercy Hospital
    Adenocarcinoma of the Colon, Stage II Colon Cancer
    Cisplatin and Radiation Therapy With or Without Tirapazamine in Treating Patients With Cervical Cancer
    Scranton Hematology Oncology

    Trial Locations
    Scranton Hematology Oncology
    Mercy Hospital
    Cervical Adenocarcinoma, Cervical Adenosquamous Cell Carcinoma, Cervical Squamous Cell Carcinoma, Stage IB Cervical Cancer, Stage IIA Cervical Cancer, Stage IIB Cervical Cancer, Stage III Cervical Cancer, Stage IVA Cervical Cancer
    Carboplatin and Paclitaxel With or Without Bevacizumab in Treating Patients With Stage III or Stage IV Ovarian Epithelial, Primary Peritoneal Cancer, or Fallopian Tube Cancer
    Mercy Hospital
    Scranton, Pennsylvania 18501
    Brenner Tumor, Fallopian Tube Cancer, Ovarian Clear Cell Cystadenocarcinoma, Ovarian Endometrioid Adenocarcinoma, Ovarian Mixed Epithelial Carcinoma, Ovarian Mucinous Cystadenocarcinoma, Ovarian Serous Cystadenocarcinoma, Ovarian Undifferentiated Adenocarcinoma, Primary Peritoneal Cavity Cancer, Stage III Ovarian Epithelial Cancer, Stage IV Ovarian Epithelial Cancer
    Cetuximab and/or Bevacizumab Combined With Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer
    Hematology and Oncology Associates of Northeastern Pennsylvania
    Scranton, Pennsylvania 18510
    Colorectal Cancer
    Hormone Therapy With or Without Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Negative Breast Cancer (The TAILORx Trial)
    Hematology and Oncology Associates of North East Pennsylvania

    Trial Locations
    Hematology and Oncology Associates of North East Pennsylvania
    Scranton Hematology Oncology
    Mercy Hospital
    Estrogen Receptor-positive Breast Cancer, HER2-negative Breast Cancer, Progesterone Receptor-positive Breast Cancer, Stage IA Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer, Stage IIIB Breast Cancer
    Cetuximab, Cisplatin, Fluorouracil, and Radiation Therapy in Treating Patients With Stage I, Stage II, or Stage III Anal Cancer
    Hematology and Oncology Associates of Northeastern Pennsylvania
    Scranton, Pennsylvania 18510
    Anal Cancer
    Bevacizumab, Radiation Therapy, and Combination Chemotherapy in Treating Patients Who Are Undergoing Surgery for Locally Advanced Nonmetastatic Rectal Cancer
    Hematology and Oncology Associates of North East Pennsylvania
    Scranton, Pennsylvania 18508
    Adenocarcinoma of the Rectum, Stage II Rectal Cancer, Stage III Rectal Cancer
    Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-Small Lung Cancer That Was Removed By Surgery
    Hematology and Oncology Associates of North East Pennsylvania

    Trial Locations
    Hematology and Oncology Associates of North East Pennsylvania
    Scranton Hematology Oncology
    Mercy Hospital
    Stage IB Non-small Cell Lung Cancer, Stage IIA Non-small Cell Lung Cancer, Stage IIB Non-small Cell Lung Cancer, Stage IIIA Non-small Cell Lung Cancer